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Abstract 
Iron acquisition is a component of Gram-negative bacteria pathogenesis, 
therefore as a form of 'nutritional immunity' host organisms sequester iron.  To obtain 
iron bacteria secrete siderophores that scavenge iron. The E. coli outer membrane 
protein FepA actively transports the siderophore ferric enterobactin into the periplasm. 
We observe this uptake reaction by fluorescently labeling FepA in live bacteria, 
monitoring quenching that occurs upon binding of FeEnt, and then fluorescence 
recovery during transport.  Energy poisons azide, arsenate, and 2,4-dinitrophenol were 
evaluated to determine sensitivity to known transport inhibitors.  We developed and 
optimized methods to screen for iron transport inhibitors using a cell-based high-
throughput screening platform. These inhibitors may have broad spectrum bacteriostatic 
antibiotic properties. 
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Chapter 1 - Introduction 
Gram-Negative Bacteria 
130 years ago Christian Gram developed what is now known as Gram staining to 
broadly classify bacteria into two groups.  Gram-positive bacteria retain the crystal violet 
stain while Gram-negative do not.  The structural differences in the cell envelope is the 
basis for this property.  Both groups contain a cellular membrane and a peptidoglycan 
layer, however Gram-negative bacteria also contain a second membrane forming the 
outermost layer (Figure 1-1).1  Peptidoglycan is a polymer of disaccharides and amino 
acids forming a rigid and generally impermeable protective mesh.2  Although both 
classifications contain a peptidoglycan layer, gram-negative bacteria have a thinner 
layer than gram-positive bacteria.1  The space between the inner and outer membranes 
that contains the peptidoglycan layer is known as the periplasm.  This periplasmic 
space also contains a large number of proteins that facilitate many important functions 
for the cell.1 
The protective outer membrane contributes to Gram-negative bacteria generally 
being more resistant to antibiotics than Gram-positive bacteria. Escherichia coli, 
Neisseria meningitidis, Pseudomonas aeruginosa, and Helicobacter pylori are all 
medically relevant bacteria with gram-negative morphology.3 
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The bacterial cell envelope provides protection from the extracellular 
environment, allows nutrients into the cell, and waste out of the cell.1  The membrane 
performs many other essential cellular processes such as energy production and lipid 
biosynthesis.1 
 
Iron 
Iron represents a vital nutrient for bacteria due to its role in many cellular 
processes such as energy production, DNA synthesis, and nitrogen fixation.4  The 
Figure 1-1 Gram-positive and Gram-negative cell envelopes 
WTA = wall teichoic acid; CAP = covalently attached protein; LTA 
= lipoteichoic acid; LPS = lipopolysaccharide; OMP = outer 
membrane protein; LP = lipoprotein; IMP = integral membrane 
protein.1 
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ability of iron to serve as a catalyst comes from the two forms of the element, ferrous 
(Fe2+) and ferric (Fe3+) iron; this allows iron be used in many reactions as a co-factor of 
many proteins.5  Nitrogenase, hydrogenase, peroxidase, superoxide dismutase, 
glutamate synthase, and cytochrome all require iron to function.4  Within these proteins, 
iron can exist in different forms as a co-factor (heme, iron-sulfur clusters, and free iron). 
Iron is also highly regulated due to the toxicity of the reduced form.4  As a result 
in biological systems iron is often complexed by other molecules as a co-factor or in 
storage.5  Eukaryotic organisms store iron in many forms such as ferritin.6 
Despite being one of the most abundant elements, iron is scarce at physiological 
conditions due to rapid oxidation to an insoluble form.7  The concentration of available 
iron can be as low as 10-9 M in an aqueous environment.8  To overcome this scarcity 
bacteria utilize several strategies to obtain iron. Hemophore proteins scavenge for heme 
and bind heme complexes.8  Bacteria also secrete low molecular weight compounds 
known as siderophores that bind ferric iron.9  Enterobactin, a 700 dalton siderophore for 
many Gram-negative bacteria has the strongest known affinity for iron (K = 1052 M-1) 
(Figure 1-2).7 
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FepA 
After iron is bound to the siderophore, ferric enterobactin (FeEnt), the bacterium 
still must internalize the complex to fulfill their nutritional requirements.  The first step 
involves crossing the outer membrane of the gram-negative bacteria.  Due to the size of 
ferric enterobactin (719 Da), the molecule can't pass through the outer membrane 
porins and requires a specific transporter.5,11  The outer membrane transporter protein 
for enterobactin in E. coli is FepA (Figure 1-3).12  This 724 residue ligand-gated porin 
contains a 22 strand antiparrallel β-barrel that spans the outer membrane with an N-
terminal plug domain that occludes the barrel.12 
Figure 1-2 Enterobactin structure 
Native siderophore of E. coli binds ferric iron.10 
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Transport of FeEnt through FepA has not been completely resolved, but the 11 
flexible loops on the extracellular side of FepA play a role in the reaction.13,14  The 
second step in the biphasic transport process is the rate-limiting step.15  Upon FeEnt 
binding the extracellular loops of FepA shift from an open to a closed conformation 
around FeEnt that allows for transport.14  The paradox of FeEnt transport involves the 
passage of FeEnt through a blocked β-barrel.  The N-terminal domain must be 
displaced in some way for FeEnt passage into the periplasm.  Several models for the 
Figure 1-3 FepA Structure 
Crystal structure of FepA with FeEnt shown from side and periplasm 
views. N-terminal globular domain is depicted in red. TonB binding 
domain is depicted in cyan.12 
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movement of the N-terminal domain have been theorized.16  Ejection of the N-terminal 
domain into the periplasm while folded, partially folded, or unfolded would allow for 
transport across the β-barrel.16  Another model suggests the N-terminal domain 
changes conformation but does not move into the periplasm.16  The proposed 
temporary channel enables transport of FeEnt across FepA.16 
 
TonB-Dependent Transport 
Transport across the outer membrane via FepA is an energy dependent process, 
and as such the membrane architecture of Gram-negative bacteria poses a challenge.17  
How can the cell power active transport processes in the outer membrane when porins, 
such as OmpF, prevent establishing an energy gradient across the outer membrane 
due to diffusion of the high-energy compounds.11 
Gram-negative bacteria have evolved an active transport system that couples 
transport across the outer membrane to energy transduction across the inner 
membrane (Figure 1-4).18  The protein complex of TonB-ExbB-ExbD along with TonB-
dependent outer membrane proteins, such as FepA, form this system.18  TonB spans 
the periplasm and interacts with TonB-dependent proteins at a conserved site known as 
the 'TonB box'.12  In FepA this site consists of amino acid residues 12-18.12  ExbB and 
ExbD stabilize TonB and provide the energy for interaction by utilizing the proton motive 
force across the inner membrane.19 
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 The interaction between TonB-dependent transporters and TonB is not fully 
elucidated.  However, the FeEnt binding to FepA induces a conformational shift in FepA 
that is transmitted to the periplasm via the TonB Box.20,21  After TonB interacts with 
FepA to allow passage into the periplasm FeEnt binds to FepB.22  This periplasmic 
protein transports FeEnt to the inner membrane protein complex of FepC-FepD-
FepG.23,24  FepC hydrolyzes cytoplasmic ATP to enable transport across the inner 
membrane, and FepD/FepG form the pore within the inner membrane.23,24 
 
Figure 1-4 Depiction of Gram-negative bacterial cell envelope architecture 
Representation of membrane architecture with iron acquisition proteins and 
other membrane proteins (figure from PE Klebba). 
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High-Throughput Screening 
In less than 30 years high-throughput screening (HTS) has emerged as a vital 
tool for the pharmaceutical industry and many other fields.  Prior to the development of 
HTS, drug discovery methods were limited to testing fewer than 50 compounds per 
week; now the screening capabilities of ultra-high throughput instrumentation exceeds 
100,000 compounds screened per day.25  Advances in combinatorial chemistry have 
enabled the creation of chemical libraries required for such large screening 
campaigns.25 Robotic automation and acoustic liquid dispensing have also contributed 
to the rapid increase in screening throughput.   Newer plate designs decrease reagent 
costs and allow for faster sampling by decreasing well size.  384, 1536, and 3456 well 
formats have largely replaced the standard 96 well plate.  The use of HTS has also 
expanded from primarily the pharmaceutical industry to academic settings.  Modern 
HTS instruments are capable of utilizing bioluminescence, fluorescence, reporter genes, 
calcium mobilization, and label-free detection methods. 
One type of HTS screening, biochemical assays, often involves a purified protein 
and ligand binding assay.  This format allows for an increased signal compared to cell-
based assays; however, cell-based assays generate more physiologically relevant 
data.26  This is increasingly important in the pharmaceutical industry due to the cost of 
late stage clinical failures.27  An increased focus on ADMET (absorption, distribution, 
metabolism, excretion and toxicity) in screening has been adopted to help prevent these 
failures.28  The power of HTS is illustrated by the discovery of the drug Torcetrapib as 
the screening campaign found only one hit after testing over 350,000 compounds.25 
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Previous Studies 
Numerous studies have been performed on FepA, enterobactin, and Gram-
negative bacterial iron acquisition system.  The basis for many of these studies is site-
directed mutagenesis of FepA.  This technique allows for cysteine substitution 
mutations in various locations within the protein.16  Labeling the mutant residues with 
fluorescent probes allows for high sensitivity monitoring during FeEnt transport.17  
Specific labeling of these residues is possible as FepA only has 2 native cysteine 
residues that exist in a disulfide bond, and cysteine residues are relatively rare among 
outer membrane proteins.12   After optimizing the labeling conditions over 75 cysteine 
mutants have been created, and the effects of fluorescent labeling on binding and 
transport has been evaluated (Figure 1-5).16 
The changes in the excitation/emission spectra during FeEnt transport help 
explain the conformational shifts of FepA.  The 7 extracellular loops of FepA move from 
an open to closed conformation around FeEnt upon binding.14  This is observed by the 
quenching of fluorescence as the local environmental changes around fluorophore are 
conferred to shifts in the spectral properties.29  It has been shown that the extracellular 
loops close around the FeEnt in a sequential manner.29 
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The susceptibility of the mutants to labeling is dependent on their accessibility to 
the extracellular environment or the periplasm at the time of labeling.29  Dual mutants 
can form disulfide bridges under oxidizing conditions and the impact on protein 
function/conformation can be assessed.16 
 
Importance 
Antibiotic resistance represents one of the greatest challenges in modern 
medicine.30  Once treatable diseases now require escalating classes of antibiotics, and 
even drugs of last resort have resistant strains.30  Besides the increased mortality due to 
Figure 1-5 FepA cysteine mutants fluorescence profiles 
Fluorescence quenching and recovery of fluorescence 
maleimide labeled extracellular loops of FepA after FeEnt 
addition at 300 seconds.29 
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ineffective treatment, the cost of resistance reaches billions of dollars in increased 
medical costs.30  Resistance arises quickly as it is highly motile between bacteria and 
with or without antibiotic selection pressure the loss of resistance is slow.30  The misuse 
of antibiotics is one reason for the increase in antibiotic resistance.3  This is one 
consequence of the increased usage of antibiotics in the medical and agricultural 
industries. 
One strategy to fight antibiotic resistance is to create new antibiotics.  Structurally 
similar drugs or drugs that target the same mechanisms are more likely to become 
ineffective, making drugs that affect new targets especially promising.3  Due to iron’s 
importance to bacterial growth and pathogenicity, an inhibitor of TonB-dependent iron 
acquisition could have novel antibiotic properties.8 
Finding inhibitors of TonB may also have theoretical importance as the 
FeEnt/FepA transporter is typical of many other Gram-negative outer membrane metal 
transporters.31  Finding additional ligands for FepA may also help elucidate the transport 
mechanisms of the protein which has yet to be completely resolved. 
 
Research Conducted in this Study 
The aim of this study was to convert and optimize previously developed low-
throughput methods of measuring iron transport for a high-throughput platform and 
ultimately to find inhibitors of TonB-dependent iron transport.  Using fluorescently 
labeled cells, transport of ferric enterobactin through FepA was observed via 
fluorescence quenching and recovery.   
12 
 
 In the first part of this study three different energy poisons (azide, arsenate, and 
2,4-dinitrophenol (DNP)) were tested to determine their IC50 values.  Given that FeEnt is 
an energy dependent process, this pathway is sensitive to disruption of the bacterial 
cellular energy supply, and as a result iron transport is inhibited.  In the absence of any 
known inhibitor of FepA, the energy poisons serve as a control in the second part of the 
study.  Low throughput data also served as a proof-of-concept prior to HTS testing. 
 The second part of the study involves the development of the HTS method.  
Several parameters (cell concentration, FeEnt concentration, control stability, and cell 
stability) were optimized.  This novel assay measures the fluorescence of bacterial cells 
before and after addition of FeEnt, and ultimately monitors transport of the ferric 
siderophore.  Using this microtiter assay we observe TonB-dependent transport and we 
can identify inhibitor of that process.  Z-factor calculations to determine the viability of 
the method were performed, and show the assay can produce statistical significance 
data. 
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Chapter 2 - Materials 
Strains 
E. coli strain OKN3 (ΔfepA) with plasmid pITS23 were used for all tests.  This 
low-copy plasmid contained FepA cysteine substitution mutant S271C.  Mutant fepA 
were under the native repressible fur promoter. 
 
Instrumentation 
Energy poison and low-throughputs studies were performed using SLM 8000 
spectrofluorometer upgraded to SLM 8100 (Aminco, USA).  440 nm and 480 nm were 
used as the excitation and emission wavelengths.  High-throughput screening 
development assays were performed on Tecan GENios Pro with black round-bottom 96 
well plates (Tecan, Switzerland) (Corning, USA).    485 nm and 535 nm were used as 
the excitation and emission wavelengths.   
 
14 
 
Chapter 3 - Methods 
Fluorescent Labeling 
We adapted previously described methods to fluorescently label cysteine 
residues in FepA.17  After inoculating cells into LB for 12 hours, we subcultured the cells 
into MOPS media for 5.5 to 6 hours, until mid-log phase (4-5 x 108 cells mL-1).  
Streptomycin (50 µg/mL) and chloremphenicol (20 µg/mL) were used as antibiotics in 
LB and MOPS media.  We collected the cells via centrifugation and resuspended in 50 
mM NaHPO4, pH 6.5 twice.  Fluorescein maleimide was added to the cells for 5 minutes 
at 5 µM.  Labeling was quenched by adding 1.3 mM 2-mercaptoethanol.  We collected 
cells via centrifugation and resuspended in phosphate buffered saline (PBS) twice.  Cell 
concentration was determined using optical density at 600 nm. 
 
Energy Poisons 
The previously described labeled cells were incubated at 37°C for 30 minutes 
with an energy poison (azide, arsenate, or DNP) at the appropriate concentration.  We 
added 5% ethanol to DNP samples for solubility.  Cells were diluted to a concentration 
of 2.5 x 107 cells mL-1 with PBS and 4% glucose and then analyzed with moderate 
mixing.  We performed energy poison studies using a 2 mL sample volume in  a SLM 
8000 fluorospectrophotometer upgraded to SLM 8100 (Aminco, USA).  After 
fluorescence readings stabilized FeEnt was added at the indicated concentrations, and 
transport of FeEnt was monitored.  We performed all samples in triplicate and the data 
15 
 
was normalized to account for variation inherent to the assay.  Data analysis was 
performed using GraFit 6.0 (Erithacus Software Ltd.). 
 
FeEnt Dilutions 
Labeled cells were incubated at 37°C for 30 minutes.  We diluted cells to a 
concentration of 2.5 x 107 cells mL-1 with PBS and 4% glucose and then analyzed with 
moderate mixing.  Measurements were performed using a 2 mL sample volume in a 
SLM 8000 fluorospectrophotometer upgraded to SLM 8100 (Aminco, USA).  We added 
FeEnt at the indicated concentration (1 to 32 nM) after fluorescence readings stabilized, 
and transport of FeEnt was then monitored.  All samples were performed in triplicate 
and the data was normalized to account for variation inherent to the assay.  We 
performed data analysis using GraFit 6.0. 
 
Cell Dilution 
The rate of depletion of extracellular FeEnt was measured over a wide range 
dilution of cell densities using Tecan GENois Pro.  We added labeled cells in triplicate to 
a 96 well plate at decreasing densities (0.250 to 0.007 cells/mL (x108)) with a total well 
volume of 190 µL.  Cells were diluted with PBS and we added 4% glucose solution as 
an energy source.    Fluorescence gain was determined prior measurements with 485 
nm and 535 nm the excitation and emission wavelengths.  After measuring unquenched 
fluorescence, FeEnt was added to all wells using the Tecan automatic injectors.  We 
used a FeEnt concentration of 200 nM to ensure maximal fluorescence quenching 
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across all cell densities.  The plate was then shaken for 10 seconds prior to measuring 
the FeEnt transport time course over 110 minutes.  We performed data analysis using 
GraFit 6.0. 
 
Cell Density 
The effect of cellular density on assay Z-factor was measured using Tecan 
GENois Pro.  We added labeled cells in triplicate to a 96 well plate at varying densities 
(0.01 to 0.5 cells/mL (x108)) with a total well volume of 190 µL.  Cells were diluted with 
PBS, and we added 4% glucose solution as an energy source.  We analyzed each cell 
concentration separately to maximize instrument sensitivity.  Fluorescence gain was 
determined prior to adding FeEnt with 485 nm and 535 nm as the excitation and 
emission wavelengths.  After measuring unquenched fluorescence for 5 cycles, 10 µL 
FeEnt was added to all wells using the Tecan automatic injectors.  Concentration of 
FeEnt corresponds to cell density to ensure the same FeEnt/cells ratio.  The plate was 
then shaken for 10 seconds prior to measuring the FeEnt transport time course over 20 
minutes.  We performed data analysis using GraFit 6.0. 
 
FeEnt Dilutions 
FeEnt concentration ranging from 2 nM to 40 nM were evaluated using Tecan 
GENois Pro.  We added labeled cells (0.1 cells/mL (x108)) to black 96 well plates in 
triplicate. Fluorescence gain was determined prior adding FeEnt with 485 nm and 535 
nm as the excitation and emission wavelengths.  After measuring unquenched 
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fluorescence for 5 cycles, FeEnt at indicated concentration was added to all wells using 
the Tecan automatic injectors.  The plate was then shaken for 10 seconds prior to 
measuring the FeEnt transport time course over 50 minutes.  We performed data 
analysis using GraFit 6.0. 
 
Z-Factor 
We used Z-factor calculations to determine the statistical significance of the HTS 
results and the viability of assay.32  To determine the statistical effect size the positive 
and negative controls were used in the calculations.  
 
 
 
Cell Stability 
The ability of cells to transport FeEnt was measured over 9 hours using Tecan 
GENois Pro.  We labeled cells as previous described and stored on ice.  Aliquots 
samples of 0.1 cells/mL (x108) were tested in triplicate at 5 time points (0, 1, 3, 5, and 9 
hours).  After measuring unquenched fluorescence, 20 nM FeEnt was added to all wells 
using the Tecan automatic injectors.  The plate was then shaken for 10 seconds prior to 
measuring the FeEnt transport time course over 95 cycles.  We performed data analysis 
using GraFit 6.0. 
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Control Stability 
The stability of the assay controls was measured over 1 hour using Tecan 
GENois Pro.  Positive control 1 injected PBS without FeEnt after 5 cycles.  In positive 
control 2, cells were incubated with 0.02 mM carbonyl cyanide m-chlorophenyl 
hydrazone (CCCP) for 30 minutes at 37°C.  Negative control consisted of cells at 0.01 
cells/mL (x108) without any energy poisons.  Labeled cells (0.1 cells/mL (x108)) were 
added to a 96 well plate with a total well volume of 190 µL.  Cells were diluted with PBS 
and we added 4% glucose solution as an energy source.  After measuring unquenched 
fluorescence for 5 cycles, FeEnt or PBS was added to all wells using the Tecan 
automatic injectors.  The plate was then shaken for 10 seconds prior to measuring the 
FeEnt transport time course over 50 minutes.  We performed data analysis using GraFit 
6.0. 
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Chapter 4 - Results 
SLM Results 
The results from energy poison studies reveal that cell were most sensitive to 
energy depletion via DNP, with arsenate the least potent.  All control samples without 
energy poisons present were shown to quench fluorescence upon adding FeEnt and 
recover fluorescence within 400 seconds.  For azide 18 mM was required to fully inhibit 
transport, and the IC50 value was 9 mM (Figure 4.1).  For arsenate 180 mM was 
required to fully inhibit transport, and the IC50 value was 90 mM (Figure 4.2).  Ethanol 
was added to control and experimental samples at 5% for solubility of DNP.  For DNP 
1.5 mM was required to fully inhibit transport, and the IC50 value was 0.75 mM (Figure 
4.3).  Two other energy poisons, CCCP and cyanide, were tested previously.29  The 
results of all five energy poisons are summarized in Table 4.1 and all concentrations 
tested in this study in Table A.1. 
To determine the effect of increasing concentrations of FeEnt on the 
fluorescence properties of iron transport via FepA we tested FeEnt at several 
concentrations (1, 2, 4, 8, 16, and 32 nM) (Figure 4.4).  The extent of fluorescence 
quenching was found to be directly related to the amount of FeEnt added, up to 16 nM.  
With both 16 nM and 32 nM the maximal extent of fluorescence quenching was 
observed.  The rate of depletion of extracellular FeEnt was observed by the recovery of 
fluorescence after quenching.  This was found to be inversely related the amount of 
FeEnt added.  Concentrations below 8 nM all fully transported FeEnt within 500 
seconds.  16 nM samples exhibited minimum fluorescence recovery over 500 seconds, 
and 32 nM samples showed no recovery over 500 seconds. 
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Using the low-throughput fluorescence platform of the SLM we developed a 
framework for a high-throughput screening assay for inhibitors of TonB-dependent iron 
transport.  By measuring fluorescence 3 times, instead of several times a second as in 
the SLM, transport can be evaluated in a high-throughput format.  The three 
measurement times, as shown in Figure 4.5 with black rectangles, occur before addition 
of FeEnt, after addition of FeEnt, and after allowing for transport of FeEnt.  Three 
possible controls were used to illustrate the assay concept.  Addition of PBS without 
FeEnt at time 0, illustrate when FepA binding is prevented.  Addition of 180 mM 
arsenate with cells illustrates when binding occurs but transport of FeEnt is prevented.  
Cells without energy poisons added represent normal binding and transport.  By 
evaluating the statistical significant differences these three points the three outcomes 
after FeEnt addition can be differentiated in a high-throughput platform. 
 
Tecan Results 
Compared to the low-throughput platform of the SLM instrumentation the high-
throughput Tecan instrumentation allows for more testing methodologies.  Instead of a 
single cuvette, 96 or 384 samples can be tested simultaneously.  We evaluated the 
relationship between cell density and FeEnt concentration using a serial cell dilution 
from 0.250 to 0.007 cells/mL (x108) (Figure 4.6).  With a constant FeEnt concentration 
for all samples of 200 nM the ratio of extracellular FeEnt to FepA was dependent on the 
cell density.  All samples had quenched fluorescence in the readings after FeEnt 
injection.  The cell density was directly related to the rate of fluorescence recovery in the 
samples.  At 0.250 cells/mL (x108) fluorescence recovered after 40 minutes but in more 
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dilute samples such as 0.007 cells/mL (x108) minimal fluorescence recovery was 
observed.  The relationship between cell concentration and signal intensity was also 
illustrated as the signal decreased as the number of cells in the well decreased. 
To determine the optimal cell concentration for the high-throughput screening we 
evaluated samples over a wide range of cell densities (Figure 4.7).  Z-factor calculations 
were performed using a data points before and after the injection of FeEnt.  The 
FeEnt/cell ratio was kept constant to ensure for consistent quenching of fluorescence.  
Table 4.2 summarizes the concentrations tested.  All samples concentrations greater 
than 0.01 cells/mL (x108) were found to have a Z-factor greater than 0.5.  The most 
dilute sample with 0.01 cells/mL (x108) exhibited a Z-factor of only 0.38. 
To determine the optimal concentration of FeEnt to be added to cells we tested 
concentration from 2 to 40 nM (Figure 4.8).  The extent of quenching was found to be 
directly related to the amount of FeEnt added.  2 nM samples fluorescence quenched to 
approximately 85% of the original intensity.   40 nM samples fluorescence quenched to 
approximately 40% of the original intensity.  The consistency of the quenching and   
fluorescence equilibrium regions was also observed with minimal variation.  In between 
these regions, the fluorescence recovery was found to be more variable, especially at 
higher concentrations of FeEnt as shown by error bars.  The results also confirm those 
found using the SLM that increasing the concentration of FeEnt decreased the rate of 
fluorescence recovery.  2 nM samples recovered almost immediately, but 40 nM 
samples had not fully recovery after 3000 seconds. 
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High-throughput screening often lasts several hours so we sought test the 
stability of labeled cells over such a time frame.  We stored cells on ice and aliquots 
were taken at the indicated time points over 9 hours and analyzed on the Tecan (Figure 
4.9).  Our results show that the samples were still able to transport FeEnt 9 hours after 
labeling while stored on ice.  All samples exhibited quenched fluorescence 
approximately 40% of the original intensity.  Very little variation was found in the speed 
of fluorescence recovery with all samples recovering fluorescence intensity within 400 
seconds. 
To determine the statistical viability and control stability of the assay in the 
Tecan, Z-factor calculations were performed on the three control samples over 3000 
seconds (Figure 4.10).  0 nM FeEnt samples exhibited stable fluorescence over the 
entire timescale with little variation.  Samples with CCCP (0.02 mM) and without CCCP 
both had quenched fluorescence after the addition of 20 nM FeEnt.  CCCP samples had 
no recovery of fluorescence over 50 minutes.  Samples without energy poisons 
recovered fluorescence and maintained that fluorescence intensity for approximately 25 
minutes.  Z-factor calculations were performed between all three controls at every data 
point.  No statistical difference exists between the three controls before the injection, but 
after injection samples with FeEnt exhibit a Z-factor of at least 0.5 when compared to 
the 0 nM FeEnt control.  Prior to recovery of fluorescence in the 0 mM CCCP sample no 
statistical difference exists when compared to the 0.02 mM CCCP sample.  After 
recovery at approximately 1500 seconds, all samples are statistically different from one 
another and maintain this for 1500 seconds.  These high Z-factors indicate that 
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significance statistical differences exist between all control samples when measured at 
three time points.  
 
 
Figure 4.1 Inhibition of FeEnt transport by azide 
We incubated OKN3/pFepAS271C cells with concentrations of sodium azide required 
for 50% inhibition (green) and 100% inhibition (blue) of fluorescence recovery caused 
via ferric enterobactin transport. 
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Figure 4.2 Inhibition of FeEnt transport by arsenate 
We incubated OKN3/pFepAS271C cells with concentrations of arsenate required for 
50% inhibition (green) and 100% inhibition (blue) of fluorescence recovery caused via 
ferric enterobactin transport. 
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Figure 4.3 Inhibition of FeEnt transport by DNP 
We incubated OKN3/pFepAS271C cells with concentrations of DNP required for 50% 
inhibition (green) and 100% inhibition (blue) of fluorescence recovery caused via ferric 
enterobactin transport. 
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Compound Concentration (mM) 
50% Inhibition 100% Inhibition 
CCCP* 0.005 0.01 
Cyanide* 2-3 5-6 
Azide 9 18 
Arsenate 90 180 
DNP 0.75 1.5 
Table 4-1 Energy poison summary 
Summary of 50% and 100% inhibition concentrations of energy poison tested.  
*Compounds previously tested.29 
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Figure 4.4 FeEnt concentration dependence on fluorescence properties 
Fluorescence of OKN3/pFepAS271C cells was quenched with variable concentrations 
of FeEnt 1 nM (red), 2 nM (orange), 4 nM (yellow), 8 nM (green), 16 nM (blue), and 32 
nM (purple).  The extent of fluorescence quenching and rate of fluorescence recovery 
were concentration dependent. 
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Figure 4.5 HTS assay design 
Assay concept distinguishes between no FeEnt binding (green), binding with transport 
(red), and binding without transport (blue).  Measurement times denoted by black 
rectangles. 
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Figure 4.6 Cell density dependence of signal fluorescence properties 
Fluorescence of OKN3/pFepAS271C cells quenched with 200 nM FeEnt.  Fluorescence 
intensity was observed over 110 minutes (blue to green). Cell density of sample ranged 
from 0.250 to 0.007 cells/mL (x108). 
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Figure 4.7 Z-factor dependence on cell density 
We calculated the Z-factor for samples with variable cell densities (0.01, 0.05, 0.10, 
0.20, 0.30, 0.40, and 0.50).  The FeEnt concentrations used were dependent on cell 
density (Table 4.2). 
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Cell Density (Cells/mL (x108)) FeEnt Concentration (nM) 
0.01 2 
0.05 10 
0.1 20 
0.2 40 
0.3 60 
0.4 80 
0.5 100 
Table 4-2 Cell and FeEnt concentrations 
Summary of Cell densities and FeEnt concentrations used in Z-factor determinations 
shown in Figure 4.7. 
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Figure 4.8 FeEnt concentration dependence on fluorescence properties 
We quenched the fluorescence of OKN3/pFepAS271C cells with variable 
concentrations of FeEnt 2 nM (red), 5 nM (orange), 10 nM (green), 20 nM (blue), and 40 
nM (purple) after the fifth measurement.  The extent of fluorescence quenching and rate 
of fluorescence recovery were concentration dependent. 
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Figure 4.9 Cell stability 
We analyzed aliquots samples of cells (0.1 Cells/mL (x108)) at the indicated time points 
(0 (red), 1 (orange), 3 (green), 5 (blue), and 9 (purple) hours) post fluorescent labeling.  
20 nM FeEnt was added after the fifth measurement. 
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Figure 4.10 Control Stability 
The fluorescence intensity of samples with (yellow and blue) or without (red) 20 nM 
FeEnt were analyzed over 50 minutes.  FeEnt was injected after the fifth measurement.  
Samples were incubated with 0.002 mM CCCP (blue) or without (red and yellow).  We 
performed Z-factor calculations at every time point between three controls (orange: red 
and yellow, green: yellow and blue, purple: red and blue) 
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Chapter 5 - Discussion 
Using fluorescence spectroscopy of mutant FepA cell enabled us to determine 
the IC50 values for 3 energy poisons, and led to the development of a HTS assay for 
inhibitors of TonB-dependent iron acquisition.  The IC50 concentration were found to be 
dependent on the type of energy poison.  We used these data in the development of the 
HTS assay.  Several different factors were evaluated during the optimization of the 
assay leading to a viable screening protocol. 
The results for the energy poisons studied show a significant difference in the 
concentration required for 50% and 100% inhibition.  Among the poisons tested CCCP 
had the lowest concentration for 50% inhibition at 0.05 mM and arsenate required 90 
mM.  This is likely due to the fact that the poisons affect different mechanisms within the 
cell.  Arsenate is a phosphate analog that prevents ATP formation during one step of 
glycolysis.  Sodium azide is an electron transport inhibitor that irreversibly binds to 
cytochrome proteins.  DNP is a proton ionophore that prevents the formation of a proton 
gradient.  CCCP also works by uncoupling ATP formation from the proton gradient.  
Cyanide is similar to sodium azide as it inhibits cytochrome c oxidase of the electron 
transport chain. 
The energy poison data collected in this study is logically supported when 
compared to the mechanism of action of the various poisons.  Proton motive force 
which energizes the translocation of FeEnt across the outer membrane via FepA is 
abolished by the two energy poisons which had the lowest inhibitory concentration.  
Poison that affect the electron transport chain by inhibiting cytochrome C such as 
36 
 
cyanide and sodium azide required higher concentration but far lower than the glycolytic 
poison arsenate.  This is likely due to the fact that the cell is far more dependent on the 
electron transport chain in terms of the amount of ATP created. 
In the development of the HTS assay several important factors needed to be 
investigated.  In order to differentiate between the three possible outcome upon the 
introduction of FeEnt we determined three measurements were required: before 
addition of FeEnt, after addition of FeEnt, and after fluorescence recovery.  However the 
energy poison data shows that at 2 nM the recovery of fluorescence after quenching 
may occur too rapidly before measurement on a HTS platform.  By observing 
fluorescence quenching using 2 nM to 32 nM FeEnt we determined that increasing the 
concentration of FeEnt allows for an increased time prior to fluorescence recovery and 
an increase extent of quenching.  This would allow for greater distinction between 
quenching and non-quenching events as the timing of measurements is critical. 
The use of a HTS platform in the Tecan GENois pro allowed for greater flexibility 
and higher throughput in the development of the assay.  To determine the correct 
concentration of cells used in the assay we determined the Z-factor over a range of cell 
concentrations.  A concentration of 0.1 cells/mL (x108) was determined to be ideal.  
Most cell-based HTS assays use cell concentrations lower than this, but we determined 
that for this assay the Z-factor was significantly lower at more dilute concentrations.  At 
0.01 cells/mL (x108) the extent of quenching is less than the other samples.  Higher 
concentrations had a similar Z-factor when compared to 0.1 cells/mL (x108), but may 
have increase turbidity.  The mixing of sample wells may also become an issue at 
higher concentrations. 
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HTS campaigns can run for several hours so it was important to determine if the 
labeled cells would maintain a consistent fluorescence profile over this time frame.  By 
evaluating aliquots over 9 hours we determined that the cells are stable when stored on 
ice.  We observed little variation between any of the samples with regard to the extent of 
quenching or the speed of fluorescence recovery.  If the HTS campaign runs for over 9 
hours additional batches of cell would be prepared as needed.  The variation between 
these cell batches could be accounted for by normalizing the data using the control 
samples. 
The design of the controls is of particular importance in HTS field.  To determine 
if an assay is viable the controls are used to calculate the Z-factor and to distinguish 
between positive and negative compounds.  Hit selection is clearly vital when the 
number of tested compound can be in the thousands.  Due to the multiple possible 
outcomes of this assay multiply controls were utilized.  We observed the three controls 
over 50 minutes and calculated the Z-factor between each control.  The differences in 
the fluorescence profile of the controls are apparent in the Z-factor calculations.  By 
utilizing three measurement time points the three possible outcome can be observed.  
The timing of these measurement while critical allows for some flexibility.  Other than 
the variable fluorescence recovery region of the 0 mM CCCP control the three controls 
exhibit stable fluorescence profiles over 50 minutes.  The stability of these controls is 
important to the throughput of the assay as specific measurement times may be 
required based on the HTS instrumentation. 
 HTS is costly and therefore many factors must be considered before screening 
compounds.  The viability of the assay to produce statistical significant results as 
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indicated by the Z-factor of approximately 0.7 is above the minimum guideline of 0.5 Z-
factor.  Our results indicate that statistical significant data can be obtained by this assay.  
Also with better instrumentation the Z-factor could increase during screening.  We 
prepared all samples in this study using micropipettes, except for FeEnt injections on 
Tecan which were performed by the automatic injectors.  HTS instrumentation with 
acoustic liquid dispensers would provide an increased level of precision over the Tecan 
Genios Pro.  This increased precision would likely decrease the well-to-well variability in 
the assay and thus lead to a higher Z-factor. 
Compared to other HTS assays the largest limitation of this assay is the lower 
throughput.  Most assays will be inherently higher-throughput than this assay as they 
measure each well only one time, and measuring each well multiple times increases the 
amount of time for each plate to be read.  The lowered throughput of the assay can be 
minimized by optimizing the timing of the measurements.  For example, after pre-
reading all plates for the pre FeEnt measurements each plate will have FeEnt injected 
and then read.  After injection and reading of all plates the plates could be restacked 
and read for the final time.  By processing the right number of plates per batch 
dependent on the instrumentation the length of time between the second and third 
measurements will allow for possibly fluorescence recovery and maximize throughput.  
Even with the most well designed assays can fail to yield positive leads; highlighted by 
the HTS for the drug Torcetrapib.  350,000 compounds were screened with only one 
hit.25 
Another important consideration before a HTS campaign is the relevance of the data.  
Targeting bacterial iron acquisition is novel pathway for drug design due to the 
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importance of iron to bacterial pathogenicity.  Another gram-negative bacteria, Yersinia 
enterocolitica, when injected with an iron-supplying compound increased in virulence 
approximately 10 million-fold.33  The need for new antibiotic that target gram negative 
bacteria is likely to increase in the future due to antibiotic resistance, and any possible 
antibiotics that might result from this screening would be less likely to exhibit resistance 
as they affect a new bacterial target.30  As FepA is characteristic of a TonB-dependent 
outer membrane transporter this novel assay may be generally used to identify 
inhibitors of TonB-dependent transport in other members of the Enterobacteriacae.30 
Not all HTS campaigns are successful and the absence of any known inhibitor of FepA 
is a concern.  However, the multiple known ligands of FepA: FeEnt (700 Da), Colicin B 
(55 kDa), and Colicin D (75 kDa) suggest that FepA can bind structurally dissimilar 
compounds.34  The mechanism by which these ligands are translocated by FepA is not 
entirely known and discovering new ligands may help to elucidate the transport 
properties of FepA. 
 
Future Work 
The future work related to this study will be running the assay at a HTS facility, 
and there are many factors which will need to be evaluated before choosing such a 
facility.  Among these HTS instrumentation and compound library are of particular 
importance.  The instrumentation must allow for the required plate handling and multiple 
measurements of each plate within one hour.  As in all HTS tests the compound library 
is vitally important, and in particular in this assay due to the lowered throughput.  Fewer 
compounds will be able to be tested so it must be ensured that the set of compounds 
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adequately samples the chemical space.  Multiplexing may also be used the increase 
the throughput of the assay and not negatively affect results. 
After running the assay the results will dictate what steps will need to be taken 
next.  If proposed inhibitors of FeEnt binding or FeEnt transport are found after the HTS 
screening secondary assays will be performed to confirm the results.  Iron transport 
assays with Fe59 can be used to verify interactions with possible inhibitors.  Depending 
on the number of possible inhibitors found the Fe59 assay may also have to be adapted 
to a HTS format, if all compound are to be tested.  Further testing may also include 
structural activity relationship (SAR) analysis, dose response, and cluster analysis. 
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Appendix A - Supplementary Figures 
  Concentration (mM) 
Arsenate 1 5 10 20 40 60 80 100 120 130 140 150 160 170 180 200 
Azide 1 2 3 4 5 6 7 8 9 10 11 13 15 16 18   
DNP 0.5 0.75 1 1.5 3   
Table A.1 Energy poison summary 
Summary of energy poison concentrations tested. 
